Aerie Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aerie pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aerie Pharmaceutical Today - Breaking & Trending Today

Aerie Pharmaceuticals Announces New Employee Inducement Grant

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

United States , North Carolina , Hans Vitzthum , Carolyn Mcauliffe , Exchange Commission , Aerie Pharmaceuticals Inc , Drug Administration , Aerie Pharmaceuticals , Aerie Pharmaceutical , Nasdaq Listing Rule , Private Securities Litigation Reform Act , Investigational New Drug Applications , New Drug Application , Sci Advisors , Business Wire , Covid 19 ,

Zacks: Analysts Expect Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to Post -$0.66 Earnings Per Share

Wall Street brokerages expect Aerie Pharmaceuticals, Inc. (NASDAQ:AERI – Get Rating) to report earnings of ($0.66) per share for the current quarter, according to Zacks. Five analysts have made estimates for Aerie Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.79) and the highest estimate coming in at ($0.59). Aerie Pharmaceuticals reported earnings […] ....

United States , Virtu Financial , Zacks Investment Research , Aerie Pharmaceuticals Inc , Needham Company , Aerie Pharmaceuticals Get Rating , Advisor Group Holdings Inc , Aerie Pharmaceuticals , Royal Bank , Wall Street , Get Rating , Aerie Pharmaceutical , Group Holdings , Virginia Retirement Systems , Nasdaq Aeri ,

Analysts Anticipate Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to Announce -$0.66 EPS

Wall Street analysts predict that Aerie Pharmaceuticals, Inc. (NASDAQ:AERI – Get Rating) will post earnings of ($0.66) per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Aerie Pharmaceuticals’ earnings. The highest EPS estimate is ($0.59) and the lowest is ($0.79). Aerie Pharmaceuticals reported earnings of ($0.72) per share in […] ....

United States , Schroder Investment Management Group , Zacks Investment Research , Aerie Pharmaceuticals Inc , Aerie Pharmaceuticals Get Rating , Needham Company , Granahan Investment Management Inc , William Blair Investment Management , Citigroup Inc , Aerie Pharmaceuticals , Wall Street , Get Rating , Aerie Pharmaceutical , Blair Investment Management , Investment Management , Investment Management Group , State Street Corp , Street Corp , Nasdaq Aeri ,